Market narrative

Read the headlines around the signals.

Move between stock news, official company releases, crypto, and FX without losing the path back to ticker research.

Latest 247wallst.com · about 8 hours ago

Here Are Monday’s Top Wall Street Analyst Research Calls: Best Buy, Circle Internet, Corning, Eaton Corporation, eBay, Ingersoll-Rand, NXP Semiconductors, Starbucks, and More

Wall Street analysts are reshuffling their bets heading into August, and some of the calls on Monday target names that range from a crypto giant to a coffee behemoth to a semiconductor darling. Find out which stocks just got slapped with new downgrades and which ones earned fresh upgrades.

Stocks

More recent coverage

Page 44
MORN seekingalpha.com · about 8 hours ago

Morningstar: Undervalued With A Differentiated Business Model

Morningstar (MORN) is a global financial services firm with a 15-year dividend growth streak, strong cash flow, and a conservative payout ratio. MORN delivered solid Q2 2026 results, beating revenue and EPS estimates, with 9.6% revenue growth and 29.2% non-GAAP EPS growth year-over-year. The stock trades at ~15.6x 2026E EPS, well below its historical 35–40x range, and is currently viewed as undervalued with a fair value estimate of $246.40.

PRCT globenewswire.com · about 8 hours ago

INVESTOR ALERT: RGRD Law Files Class Action Lawsuit Against PROCEPT BioRobotics Corporation and Announces Opportunity for Investors with Substantial Losses to Lead the Procept Class Action Lawsuit - PRCT

SAN DIEGO, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) common stock between February 28, 2024 and February 25, 2026, both dates inclusive (the “Class Period”), have until September 22, 2026 to seek appointment as lead plaintiff of the Procept class action lawsuit. Captioned Operating Engineers Construction Industry and Miscellaneous Pension Fund v.

L proactiveinvestors.com · about 8 hours ago

Hotels and pipelines drive Loews profits higher as insurance underwriting softens

Loews Corp (NYSE:L), the New York-listed conglomerate with interests in insurance, pipelines, hotels and packaging, reported second-quarter net income of $444 million as its smaller businesses picked up the slack from a weakening insurance market. That compares with $391 million a year earlier, with earnings per share rising to $2.16 from $1.87.

IVV benzinga.com · about 8 hours ago

S&P 500 Faces ‘Worst Two Months' of the Year: Wall Street Strategist Warns Investors to Brace for August and September Volatility

Chief Market Strategist at Carson Research, Ryan Detrick, is advising S&P 500 investors to prepare for seasonal headwinds, cautioning that markets should brace for August and September, as they are historically the “worst two months” of the year. The warning follows a rare back-to-back monthly decline for the index in June and July.

TGT prnewswire.com · about 8 hours ago

Target Hospitality Announces Second Quarter 2026 Earnings Release and Conference Call Schedule

THE WOODLANDS, Texas, Aug. 3, 2026 /PRNewswire/ -- (PRNewswire) – Target Hospitality Corp. ("Target Hospitality", "Target" or the "Company") (NASDAQ: TH), one of North America's largest providers of vertically integrated modular accommodations and value-added hospitality services, today announced that it will release its second quarter 2026 financial results before the market opens on Monday, August 10, 2026. The Company has also scheduled a conference call for Monday, August 10, 2026, at 9:00 am Eastern Time (8:00 am Central Time) to discuss the results.

GDDY newsfilecorp.com · about 8 hours ago

Kaplan Fox Advises Investors of GoDaddy Inc. (GDDY) of an Investigation into Possible Securities Law Violations

New York, New York--(Newsfile Corp. - August 3, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against GoDaddy Inc. ("GoDaddy" or the "Company") (NYSE: GDDY). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a GoDaddy investor and have suffered losses, or if you have information that could assist in the GoDaddy investigation, you may CLICK HERE to contact us.

LLY prnewswire.com · about 8 hours ago

Lilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer

INDIANAPOLIS, Aug. 3, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to olomorasib as a monotherapy for the treatment of adult patients with advanced pancreatic cancer who have received at least one prior systemic therapy and have a KRAS G12C mutation, as determined by an FDA-approved test. Olomorasib is an investigational, potent and highly selective next-generation inhibitor of KRAS G12C.

PSNL globenewswire.com · about 8 hours ago

PERSONALIS SHAREHOLDER ALERT: PSNL Shareholders Interested in Pursuing Potential Claims Should Contact Julie & Holleman Regarding Proposed Sale to Tempus

NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Julie & Holleman LLP, a nationally recognized shareholder rights firm, is investigating the proposed acquisition of Personalis, Inc. (Nasdaq: PSNL) by Tempus AI, Inc. (Nasdaq: TEM), an existing Personalis shareholder and strategic partner. For a free consultation, please visit https://julieholleman.com/personalis-inc/.

SCHQ seekingalpha.com · about 8 hours ago

SCHQ: Risks Could Continue To Mount For Duration Bets

The Schwab Long-Term US Treasury ETF (SCHQ) offers high liquidity and low expense ratio, tracking long-duration US Treasuries with a 13.8-year effective duration. But caution is needed with duration, citing persistent inflation risks, hawkish Fed posture, and geopolitical tensions that pressure long-term yields upward. Geopolitical instability and structural inflation pose significant threats to the forward rates, reflected in sharp changes on the long-side of the yield curve in particular.

EXC seekingalpha.com · about 8 hours ago

Exelon: A Solid Utility, But The Upside Is Already Priced In

Exelon reported a solid Q2 2026, with a revenue beat, slight EPS miss, and guidance reaffirmed. EXC's pure T&D model, 7.9% rate base growth, and stable regulatory environment underpin its quality profile. The data center pipeline was cut from 43GW to 36GW, raising caution amid AI-driven utility premium valuations.

← Newer
Older →